Laser Acupuncture for Postpartum Weight Retention

Chang Gung Medical Foundation

Status and phase

Completed

Phase 3

Conditions

Postpartum Weight Retention

Treatments

Procedure: laser acupuncture

Procedure: sham laser acupuncture

Study type

Interventional

Funder types

Other

Identifiers

NCT02840916

CMRPG8C0691

Details and patient eligibility

About

Objective: To determine the therapeutic effect of acupuncture on postpartum weight retention.

Methods: 66 subjects after delivery with postpartum weight retention will be randomly divided into laser acupuncture and control group. A single-blind clinical trial will be conducted and the subjects will be treated with verum or sham laser acupuncture 5 sessions per week. After about 3 weeks of treatment, the differences of the subjects' body weight, body mass index, and waist circumference will be analyzed with ANOVA between laser acupuncture and control group.

Full description

Objective: Gestational weight gain and weight retention at 1 year after delivery are associated with long-term obesity. The investigators aimed to investigate the effect of laser acupuncture therapy (LAT) on postpartum weight control.

Methods: The investigators randomly assigned 66 subjects with postpartum weight retention to a laser acupuncture group and control group. The subjects were treated at acupoints including the Stomach and Hunger points of the ear, ST25 (Tianshu), ST28 (Shuidao), ST40 (Fenglong), SP15 (Daheng), CV9 (Shuifen), and SP6 (Sanyinjiao) by using verum or sham laser acupuncture over 5 sessions per week. After 12 treatment sessions, the differences in the body mass index (BMI), body fat percentage (BFP), and waist-to-buttocks ratio (WBR) of the patients were analyzed, and compared between the laser acupuncture and control groups via analysis of variance, chi-square tests, and stepwise regression tests.

Enrollment

66 patients

Sex

Female

Ages

20 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

postpartum duration of <1 month;
body mass index (BMI) > 25;
age > 20 years;
did not use any other medications for weight loss during the study period; and
provided informed consent.

Exclusion criteria

presence of a pacemaker;
history of seizure or epilepsy;
taking immunosuppressant medication;
cancer;
infectious disease of the skin;
taking medications for weight loss, including Chinese herbal preparations, during the study period;
receiving other treatment, including supplements, herbs, and medications for weight gain prior to entering the study;
comorbidities (hypothyroidism, renal disease, etc.) that the physician believes would affect the findings;
unable to undergo LAT due to other medical conditions; and
lack of informed consent.